Specialty code 183500000X · Tracy, CA
NPI
1477702702
Since 2008
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2185 W Grant Line Rd
Tracy, CA, 95377
Phone (209) 839-6221
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$472K
2,386 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tanisha L Robinson-Wiley prescribed most often to Medicare patients was Atorvastatin Calcium, with 257 prescriptions and refills. In total Tanisha L Robinson-Wiley wrote 2,386 Medicare prescriptions that cost $472K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 257 | 856 | 103 | $3,247 |
| Ozempic Semaglutide | 248 | 259 | 38 | $184K |
| Glipizide Generic | 195 | 637 | 69 | $2,569 |
| Metformin Hcl Generic | 187 | 623 | 77 | $2,454 |
| Metformin Hcl Er Metformin Hcl | 180 | 594 | 73 | $1,716 |
| Humulin N Insulin Nph Human Isophane | 160 | 496 | 61 | $36K |
| Jardiance Empagliflozin | 154 | 510 | 57 | $103K |
| Lisinopril Generic | 104 | 344 | 36 | $1,205 |
| Humulin R Insulin Regular, Human | 79 | 243 | 30 | $18K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 77 | 231 | 35 | $1,885 |
| Glipizide Er Glipizide | 70 | 233 | 31 | $2,180 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 54 | 169 | 20 | $1,368 |
| Amlodipine Besylate Generic | 49 | 163 | 21 | $609 |
| Losartan Potassium Generic | 46 | 153 | 18 | $590 |
| Simvastatin Generic | 43 | 143 | 13 | $528 |
Brand drugs: 849 claims; generic drugs: 1,344 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tanisha L Robinson-Wiley were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.